NCT01147731View on ClinicalTrials.gov

A Drug Interaction Study With Albiglutide and Warfarin

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 4, 2010

Primary Completion Date

September 9, 2010

Study Completion Date

September 9, 2010

Conditions
Diabetes Mellitus, Type 2
Interventions
BIOLOGICAL

warfarin plus albiglutide

A single dose of 25mg warfarin on day 1 followed by 5 weekly doses of subcutaneous albiglutide followed by a single dose of 25mg warfarin on day 45.

Trial Locations (1)

78744

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY